Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature.

Sartori D, Aronson JK, Onakpoya IJ

Open source

DOI
10.1186/s13643-020-01429-z
Published
2020 Aug 13
Container
Systematic reviews
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13643-020-01429-z,
  title = {Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature.},
  author = {Sartori D and Aronson JK and Onakpoya IJ},
  year = {2020},
  journal = {Systematic reviews},
  doi = {10.1186/s13643-020-01429-z},
  url = {https://doi.org/10.1186/s13643-020-01429-z}
}

RIS

TY  - JOUR
TI  - Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature.
AU  - Sartori D
AU  - Aronson JK
AU  - Onakpoya IJ
PY  - 2020
JO  - Systematic reviews
DO  - 10.1186/s13643-020-01429-z
UR  - https://doi.org/10.1186/s13643-020-01429-z
ER  - 

APA

D, S., JK, A., & IJ, O. (2020). Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature.. Systematic reviews. https://doi.org/10.1186/s13643-020-01429-z

Source records